{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:26:22Z","timestamp":1790785582184,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tmaid.2026.102972","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:02:09Z","timestamp":1773968529000},"page":"102972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Towards national guidance on dengue and chikungunya vaccination in travellers: Lessons from global recommendations"],"prefix":"10.1016","volume":"71","author":[{"given":"Anna","family":"Bogacka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Wroczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8780-0304","authenticated-orcid":false,"given":"Maciej","family":"Grzybek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2026.102972_bib1","volume":"vol. 1","year":"2024"},{"key":"10.1016\/j.tmaid.2026.102972_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2017.11.026","article-title":"Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus","volume":"67","author":"Leta","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007213","article-title":"Global expansion and redistribution of Aedes-borne virus transmission risk with climate change","volume":"13","author":"Ryan","year":"2019","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijidoh.2025.100058","article-title":"Global expansion of Aedes mosquitoes and their role in the transboundary spread of emerging arboviral diseases: a comprehensive review","volume":"6","author":"Abbasi","year":"2025","journal-title":"IJID One Health"},{"key":"10.1016\/j.tmaid.2026.102972_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/vbz.2022.0071","article-title":"Incidence of lyme borreliosis in Europe from national surveillance systems (2005\u20132020)","volume":"23","author":"Burn","year":"2023","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib7","year":"2025","journal-title":"Dengue"},{"key":"10.1016\/j.tmaid.2026.102972_bib12","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.40.19677-en","article-title":"Dengue virus infection in a traveller returning from Croatia to Germany","volume":"15","author":"Schmidt-Chanasit","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2026.102972_bib13","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"Infection with chikungunya virus in Italy: an outbreak in a temperate region","volume":"370","author":"Rezza","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2026.102972_bib15","unstructured":"EMA. Ixchiq n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ixchiq (accessed October 31, 2025)."},{"key":"10.1016\/j.tmaid.2026.102972_bib16","series-title":"IXCHIQ vaccine approved to protect adults against Chikungunya","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/v12080829","article-title":"Dengue: a minireview","volume":"12","author":"Harapan","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2026.102972_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00284-020-02284-w","article-title":"Current understanding of the pathogenesis of Dengue virus infection","volume":"78","author":"Bhatt","year":"2021","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.tmaid.2026.102972_bib19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jiph.2023.08.001","article-title":"Dengue overview: an updated systemic review","volume":"16","author":"Khan","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.tmaid.2026.102972_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/v16050769","article-title":"Retrospective analysis of severe dengue by dengue virus serotypes in a population with social security, Mexico 2023","volume":"16","author":"Hern\u00e1ndez Bautista","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2026.102972_bib21","series-title":"WHO. Chikungunya","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1874312901610010129","article-title":"A review of Chikungunya virus-induced arthralgia: clinical manifestations, therapeutics, and pathogenesis","volume":"10","author":"Goupil","year":"2016","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.tmaid.2026.102972_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2026.102972_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(13)70150-9","article-title":"Neurological complications of dengue virus infection","volume":"12","author":"Carod-Artal","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tmaid.2026.102972_bib25","article-title":"The neurological complications of chikungunya virus: a systematic review","volume":"28","author":"Mehta","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.tmaid.2026.102972_bib26","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent Dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2026.102972_bib27","unstructured":"EMA. Qdenga n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/qdenga (accessed October 31, 2025)."},{"key":"10.1016\/j.tmaid.2026.102972_bib28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/14760584.2025.2490295","article-title":"TAK-003: development of a tetravalent dengue vaccine","volume":"24","author":"S\u00e1ez-Llorens","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2026.102972_bib29","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Tricou","year":"2024","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.tmaid.2026.102972_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taae084","article-title":"Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine","volume":"31","author":"Buerger","year":"2024","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2026.102972_bib31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/vaccines12080893","article-title":"The approved live-attenuated Chikungunya Virus Vaccine (IXCHIQ\u00ae) elicits cross-neutralizing antibody breadth extending to multiple arthritogenic alphaviruses similar to the antibody breadth following natural infection","volume":"12","author":"Weber","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tmaid.2026.102972_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(24)00357-8","article-title":"Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study","volume":"24","author":"McMahon","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib33","series-title":"FDA update on the safety of Ixchiq (Chikungunya vaccine, live)","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib34","series-title":"Chikungunya vaccine information for healthcare providers","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib36","series-title":"Epidemiological Update - Chikungunya in the Region of the Americas - 22 April 2024","year":"2024"},{"key":"10.1016\/j.tmaid.2026.102972_bib37","series-title":"Historical data on local transmission in the EU\/EEA of chikungunya virus disease n.d. historical data on local transmission in the EU\/EEA of chikungunya virus disease","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib44","series-title":"Communicable disease threats report 2025. 2025-WCP-0037 draft","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib46","series-title":"STIKO recommendation on vaccination against chikungunya","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib47","year":"2024","journal-title":"Dengue"},{"key":"10.1016\/j.tmaid.2026.102972_bib49","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.57187\/s.3858","article-title":"Vaccination against dengue fever for travellers","volume":"154","author":"Eperon","year":"2024","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.tmaid.2026.102972_bib51","series-title":"Strat\u00e9gie de vaccination contre la dengue - place du vaccin Qdenga","year":"2024"},{"key":"10.1016\/j.tmaid.2026.102972_bib53","author":"Alders"},{"key":"10.1016\/j.tmaid.2026.102972_bib54","series-title":"Chikungunya vaccination","author":"Alders","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib56","series-title":"CATMAT guidance on the use of the live-attenuated chikungunya vaccine (IXCHIQ) in persons 65 years or older","year":"2025"},{"key":"10.1016\/j.tmaid.2026.102972_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue Serostatus on Dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2026.102972_bib58","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","article-title":"Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age","volume":"35","author":"Halstead","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2026.102972_bib59","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/infdis\/jiac272","article-title":"Specificity and breadth of the neutralizing antibody response to a live-attenuated tetravalent Dengue vaccine","volume":"226","author":"DeMaso","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib60","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S2214-109X(23)00590-9","article-title":"TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden","volume":"12","author":"Wilder-Smith","year":"2024","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.tmaid.2026.102972_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.975398","article-title":"Serological cross-reactivity among common flaviviruses","volume":"12","author":"Chan","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.tmaid.2026.102972_bib62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v13040596","article-title":"Different cross-reactivities of IgM responses in Dengue, zika and tick-borne encephalitis virus infections","volume":"13","author":"Stiasny","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2026.102972_bib63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/diagnostics10050302","article-title":"Serological diagnosis of flavivirus-associated human infections","volume":"10","author":"Musso","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.tmaid.2026.102972_bib65","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue Plaque Reduction Neutralization Test (PRNT) in primary and secondary Dengue virus infections: how alterations in assay conditions impact performance","volume":"81","author":"Thomas","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2026.102972_bib66","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2026.102972_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf550","article-title":"Fatal adverse event after VLA1553 Chikungunya vaccination in an elderly patient: a case report from Reunion Island","volume":"12","author":"Mosnier","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib68","author":"Takeda"},{"key":"10.1016\/j.tmaid.2026.102972_bib69","author":"Updated"},{"key":"10.1016\/j.tmaid.2026.102972_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2301573","article-title":"Ixchiq (VLA1553): the first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection","volume":"15","author":"Ly","year":"2024","journal-title":"Virulence"},{"key":"10.1016\/j.tmaid.2026.102972_bib71","series-title":"(accessed November 3, 2025)","article-title":"FDA approves first vaccine to prevent disease caused by Chikungunya Virus","year":"2023"},{"key":"10.1016\/j.tmaid.2026.102972_bib72","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1473-3099(25)00552-3","article-title":"More data needed on the FDA's decision to suspend Ixchiq","volume":"25","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2026.102972_bib73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40259-024-00677-y","article-title":"Chikungunya virus vaccines: a review of IXCHIQ and PXVX0317 from pre-clinical evaluation to licensure","volume":"38","author":"Weber","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.tmaid.2026.102972_bib74","article-title":"IXCHIQ chikungunya vaccine: updates to restrictions of use following safety review","year":"2026","journal-title":"Drug Safety Update"},{"key":"10.1016\/j.tmaid.2026.102972_bib76","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.32.2500543","article-title":"Surveillance for adverse events following use of live attenuated chikungunya vaccine, United States, 2024, and the associated public health response in 2024 and 2025","volume":"30","author":"Hills","year":"2025","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.tmaid.2026.102972_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0014038","article-title":"Tropical diseases in the context of climate change and emerging European transmission","volume":"20","author":"Grzybek","year":"2026","journal-title":"PLoS Neglected Trop Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893926000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893926000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:12:14Z","timestamp":1784034734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893926000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":57,"alternative-id":["S1477893926000220"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2026.102972","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards national guidance on dengue and chikungunya vaccination in travellers: Lessons from global recommendations","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2026.102972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102972"}}